Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.

Ipilimumab plus Decitabine for Patients with MDS or AML in Post-Transplant or Transplant Naïve Settings

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.

L. Penter, Yang Liu, J. Wolff, et al. (2023). Blood. Cited 42 times. https://doi.org/10.1182/blood.2022018246

Ipilimumab plus decitabine for patients with MDS or AML in post-transplant or transplant naïve settings.

Jacqueline S. Garcia, Yael Flamand, L. Penter, et al. (2022). Blood. Cited 35 times. https://doi.org/10.1182/blood.2022017686